We are live on ! Find out more
PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings

AUM $73.6M
1-Year Est. Return 61.93%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+61.93%
3 Year Est. Return
+167.56%
5 Year Est. Return
+341.85%
10 Year Est. Return
+2,192.73%
AUM
$120M
AUM Growth
+$3.1M
Cap. Flow
-$2.15M
Cap. Flow %
-1.79%
Top 10 Hldgs %
82.37%
Holding
26
New
3
Increased
7
Reduced
3
Closed
6

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$7.21M
2
DAL icon
Delta Air Lines
DAL
+$6.53M
3
OXY icon
Occidental Petroleum
OXY
+$5.09M
4
LUV icon
Southwest Airlines
LUV
+$2.35M
5
C icon
Citigroup
C
+$2.22M

Sector Composition

Rank Sector Weight
1 Energy 25.3%
2 Healthcare 22.47%
3 Financials 17.05%
4 Industrials 12.04%
5 Technology 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$13.3M 11.1%
50,000
+5,000
+11% +$1.3M
C icon
2
Citigroup
C
$231B
$13M 10.83%
175,000
+30,000
+21% +$2.22M
NVGS icon
3
Navigator Holdings
NVGS
$1.26B
$11.5M 9.53%
1,163,028
DAL icon
4
Delta Air Lines
DAL
$59.1B
$11.2M 9.32%
200,000
+125,000
+167% +$6.53M
OXY icon
5
Occidental Petroleum
OXY
$58.5B
$11M 9.19%
150,000
+75,000
+100% +$5.09M
IRIX icon
6
IRIDEX
IRIX
$15.1M
$9.53M 7.92%
1,250,000
PARR icon
7
Par Pacific Holdings
PARR
$3.9B
$7.91M 6.58%
410,000
-86,960
-17% -$1.76M
MS icon
8
Morgan Stanley
MS
$342B
$7.48M 6.22%
+142,500
New +$7.21M
RETA
9
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7.08M 5.89%
250,000
CDNA icon
10
CareDx
CDNA
$2.45B
$6.96M 5.79%
948,000
-325,800
-26% -$2.03M
QADA
11
DELISTED
QAD Inc.
QADA
$3.5M 2.91%
90,000
+25,000
+38% +$940K
LUV icon
12
Southwest Airlines
LUV
$22B
$3.27M 2.72%
50,000
+40,000
+400% +$2.35M
HHH icon
13
Howard Hughes
HHH
$3.98B
$2.63M 2.18%
20,980
ESXB
14
DELISTED
Community Bankers Trust Corporation
ESXB
$2.3M 1.92%
282,648
-215,687
-43% -$1.86M
SGI
15
Somnigroup International
SGI
$13.5B
$1.88M 1.56%
+120,000
New +$1.83M
ZBH icon
16
Zimmer Biomet
ZBH
$18.7B
$1.81M 1.51%
15,450
HAIN icon
17
Hain Celestial
HAIN
$52.9M
$1.7M 1.41%
40,000
+30,000
+300% +$1.19M
AGN
18
DELISTED
Allergan plc
AGN
$1.64M 1.36%
+10,000
New +$1.79M
TUES
19
DELISTED
Tuesday Morning Corp
TUES
$450K 0.37%
163,709
AAT
20
American Assets Trust
AAT
$1.39B
-5,000
Closed -$199K
BLDR icon
21
Builders FirstSource
BLDR
$7.79B
-275,795
Closed -$4.96M
GS icon
22
Goldman Sachs
GS
$302B
-20,000
Closed -$4.74M
IWM icon
23
iShares Russell 2000 ETF
IWM
$82.2B
-35,000
Closed -$5.19M
PACW
24
DELISTED
PacWest Bancorp
PACW
-169,681
Closed -$8.57M
BSFT
25
DELISTED
BroadSoft, Inc.
BSFT
-25,000
Closed -$1.26M

Similar funds

Paragon Associates & Paragon Associates II Joint Venture's Q4 2017 Portfolio in Review

As of Q4 2017, Paragon Associates & Paragon Associates II Joint Venture held 26 positions worth $120M, up 2.6% from $117M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Paragon Associates & Paragon Associates II Joint Venture's Q4 2017 filing shows 3 new, 7 increased, 3 reduced and 6 closed positions. Its largest new stake was Morgan Stanley: 142,500 shares worth $7.48M. The largest sale was PacWest Bancorp, an estimated $8.57M.

By sector, the portfolio is most concentrated in Energy at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Paragon Associates & Paragon Associates II Joint Venture's largest Q4 2017 buy was Morgan Stanley: 142,500 shares worth $7.48M.
  • Paragon Associates & Paragon Associates II Joint Venture added most to Delta Air Lines in Q4 2017, an estimated $6.53M increase.
  • Paragon Associates & Paragon Associates II Joint Venture's biggest Q4 2017 reduction was CareDx, cutting an estimated $2.03M.
  • Paragon Associates & Paragon Associates II Joint Venture fully exited PacWest Bancorp in Q4 2017, selling an estimated $8.57M.
  • Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 82% of its $120M portfolio in Q4 2017.
  • Paragon Associates & Paragon Associates II Joint Venture opened 3 new positions and closed 6 in Q4 2017.
  • Paragon Associates & Paragon Associates II Joint Venture's portfolio value rose 2.6% quarter-over-quarter to $120M.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q4 2017, filed 13 Feb 2018.